| DAA19 |
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 |
Molecular |
brain |
Human |
ATP6V0D1 |
8.0% Decrease Gene Expression Level |
|
| DAA20 |
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
Molecular |
brain |
Human |
ATP6V1A |
7.0% Decrease Gene Expression Level |
|
| DAA2041 |
Altered brain mitochondrial metabolism |
Physiological |
brain |
Human |
— |
— |
|
| DAA748 |
Altered sleep parameters and patterns |
Psychological |
brain |
Human |
— |
— |
|
| DAA723 |
Accumulation of extracellular neuritic plaques |
Physiological |
brain |
Human |
— |
— |
|
| DAA615 |
Alzheimer's disease |
Pathological |
brain |
Human |
— |
SeriesMorbidity |
|
| DAA761 |
Activation threshold for long-term potentiation is increased |
Psychological |
brain |
Human |
— |
— |
|
| DAA18 |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
Molecular |
brain |
Human |
ATP5B |
9.0% Decrease Gene Expression Level |
|
| DAA8 |
angiomotin |
Molecular |
brain |
Human |
AMOT |
10.0% Increase Gene Expression Level |
|
| DAA24 |
B-cell CLL/lymphoma 11A (zinc finger protein) |
Molecular |
brain |
Human |
BCL11A |
14.0% Decrease Gene Expression Level |
|
| DAA23 |
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
Molecular |
brain |
Human |
B3GALNT1 |
22.0% Decrease Gene Expression Level |
|
| DAA1996 |
Beta-amyloid protein deposition increases |
Physiological |
brain |
Human |
APP |
— |
|
| DAA25 |
bone morphogenetic protein 7 |
Molecular |
brain |
Human |
BMP7 |
20.0% Increase Gene Expression Level |
|
| DAA728 |
Brain matter volume declines |
Physiological |
brain |
Human |
— |
— |
|
| DAA1217 |
Brain volume decrease |
Physiological |
brain |
Human |
— |
— |
|
| DAA1993 |
Brain volume decreases in a regional-specific way |
Physiological |
brain |
Human |
— |
— |
|
| DAA33 |
calbindin 1, 28kDa |
Molecular |
brain |
Human |
CALB1 |
58.0% Decrease Gene Expression Level |
|
| DAA765 |
Calcium binding capacity decreases in neurons |
Physiological |
brain |
Human |
— |
— |
|
| DAA36 |
calcium/calmodulin-dependent protein kinase IV |
Molecular |
brain |
Human |
CAMK4 |
17.0% Decrease Gene Expression Level |
|
| DAA37 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
Molecular |
brain |
Human |
CAMKK2 |
7.0% Decrease Gene Expression Level |
|
| DAA32 |
calcium channel, voltage-dependent, beta 2 subunit |
Molecular |
brain |
Human |
CACNB2 |
8.0% Decrease Gene Expression Level |
|
| DAA34 |
calmodulin 1 (phosphorylase kinase, delta) |
Molecular |
brain |
Human |
CALM1 |
5.0% Decrease Gene Expression Level |
|
| DAA35 |
calmodulin 3 (phosphorylase kinase, delta) |
Molecular |
brain |
Human |
CALM3 |
10.0% Decrease Gene Expression Level |
|
| DAA44 |
carbamoyl-phosphate synthetase 1, mitochondrial |
Molecular |
brain |
Human |
CPS1 |
20.0% Increase Gene Expression Level |
|
| DAA4 |
actin, beta |
Molecular |
brain |
Human |
ACTB |
4.0% Decrease Gene Expression Level |
|